Cargando…
82. Incidence rates of invasive aspergillosis among lung transplant recipients in timeperiods with universal and targeted antifungal prophylaxis - a nationwide cohort study
BACKGROUND: The best stategy for prevention of invasive aspergillosis (IA) after lung transplantation (LTX) has not been determined. In 2016, Danish guidelines for IA prophylaxis was changed from 12 weeks of universal prophylaxis with voriconazole to targeted prophylaxis with posaconazole and inhale...
Autores principales: | Crone, Cornelia G, Wulff, Signe Marie, Ledergerber, Bruno, Bredahl, Pia, Helweg-Larsen, Jannik, Arendrup, Maiken C, Perch, Michael, Helleberg, Marie |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9752343/ http://dx.doi.org/10.1093/ofid/ofac492.007 |
Ejemplares similares
-
Invasive Aspergillosis among Lung Transplant Recipients during Time Periods with Universal and Targeted Antifungal Prophylaxis—A Nationwide Cohort Study
por: Crone, Cornelia Geisler, et al.
Publicado: (2023) -
Adverse Events Associated with Universal versus Targeted Antifungal Prophylaxis among Lung Transplant Recipients—A Nationwide Cohort Study 2010–2019
por: Crone, Cornelia Geisler, et al.
Publicado: (2022) -
Pulmonary mucormycosis in the aftermath of critical COVID-19 in an immunocompromised patient: Mind the diagnostic gap
por: Crone, Cornelia Geisler, et al.
Publicado: (2022) -
Intensive Care Antifungal Stewardship Programme Based on T2Candida PCR and Candida Mannan Antigen: A Prospective Study
por: Helweg-Larsen, Jannik, et al.
Publicado: (2021) -
Invasive aspergillosis in patients with severe COVID-19 pneumonia
por: Helleberg, Marie, et al.
Publicado: (2021)